Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis
Crossref DOI link: https://doi.org/10.1007/s40744-017-0057-3
Published Online: 2017-02-27
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hudry, Christophe
Lebrun, Agnès
Moura, Bertrand
Zinovieva, Elena
Backers, Onne
Herman-Demars, Hélène
Funding for this research was provided by:
Nordic Pharma